These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18669715)

  • 1. Maternal biochemical serum screening for Down syndrome in pregnancy with human immunodeficiency virus infection.
    Le Meaux JP; Tsatsaris V; Schmitz T; Fulla Y; Launay O; Goffinet F; Azria E
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):223-30. PubMed ID: 18669715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
    Brossard P; Boulvain M; Coll O; Barlow P; Aebi-Popp K; Bischof P; Martinez de Tejada B; ;
    AIDS; 2008 Oct; 22(15):2013-7. PubMed ID: 18784463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of protease inhibitors on maternal serum screening analyte levels in pregnant women who are HIV positive.
    Einstein FH; Wright RL; Trentacoste S; Gross S; Merkatz IR; Bernstein PS
    Am J Obstet Gynecol; 2004 Sep; 191(3):1004-8. PubMed ID: 15467580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women.
    Sritippayawan S; Vachirasrisoontra C
    J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined first-trimester Down syndrome screening in HIV-infected women.
    Chougrani I; Muller F; Marcelin L; Tsatsaris V; Abric J; Luton D; Guibourdenche J; Azria E
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():274-8. PubMed ID: 27391901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance.
    Rudnicka AR; Wald NJ; Huttly W; Hackshaw AK
    Prenat Diagn; 2002 Oct; 22(10):893-7. PubMed ID: 12378572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
    Rice JD; McIntosh SF; Halstead AC
    Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
    Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
    Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.
    Huttly W; Rudnicka A; Wald NJ
    Prenat Diagn; 2004 Oct; 24(10):804-7. PubMed ID: 15503275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
    Wald NJ; Morris JK; Ibison J; Wu T; George LM
    Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
    Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
    Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between maternal serum alpha-fetoprotein and maternal haemoglobin.
    Bartha JL; Omar KM; Soothill PW
    Prenat Diagn; 2004 Aug; 24(8):609-12. PubMed ID: 15305347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
    Hu YL;
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free fetal DNA levels in pregnancies conceived by IVF.
    Pan PD; Peter I; Lambert-Messerlian GM; Canick JA; Bianchi DW; Johnson KL
    Hum Reprod; 2005 Nov; 20(11):3152-6. PubMed ID: 16006472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal screening for Down syndrome: the problem of recurrent false-positives.
    Wald NJ; Huttly WJ; Rudnicka AR
    Prenat Diagn; 2004 May; 24(5):389-92. PubMed ID: 15164416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies.
    Huang T; Boucher K; Summers AM
    Prenat Diagn; 2007 Dec; 27(12):1138-42. PubMed ID: 17960787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study.
    Dreux S; Nguyen C; Czerkiewicz I; Schmitz T; Azria E; Fouré MA; Muller F;
    Am J Obstet Gynecol; 2013 May; 208(5):397.e1-5. PubMed ID: 23353023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.